Enpiar Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 4.96 Cr
as on 20-12-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.96 Cr
as on 20-12-2024
- Satisfied Charges ₹ 3.80 M
as on 20-12-2024
- Revenue 3.75%
(FY 2019)
- Profit -0.85%
(FY 2019)
- Ebitda 5.25%
(FY 2019)
- Net Worth 2.30%
(FY 2019)
- Total Assets -6.66%
(FY 2019)
About Enpiar Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.96 Cr.
The company currently has active open charges totaling ₹2.96 Cr. The company has closed loans amounting to ₹3.80 M, as per Ministry of Corporate Affairs (MCA) records.
Duvvuru Abhiram and Srikanth Ketamreddy serve as directors at the Company.
- CIN/LLPIN
U24230TG1994PTC016876
- Company No.
016876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationAndhra Pradesh, Telangana
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Enpiar Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Duvvuru Abhiram  | Director | 05-Dec-2013 | Current |
| Srikanth Ketamreddy | Director | 25-Jun-2020 | Current |
Financial Performance of Enpiar Pharma.
Enpiar Pharma Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.75% increase. The company also saw a slight decrease in profitability, with a 0.85% decrease in profit. The company's net worth moved up by a moderate rise of 2.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enpiar Pharma?
In 2019, Enpiar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pavanasuta Renewable Energy Private LimitedActive 9 years 10 monthsDuvvuru Abhiram is a mutual person
Agni Interactive Gaming Solutions Private LimitedActive 14 years 8 monthsDuvvuru Abhiram is a mutual person
- Credence Imaging And Diagnostics Private LimitedActive 10 years 6 months
Duvvuru Abhiram is a mutual person
- United Radio-Imaging Services Private LimitedActive 9 years 9 months
Duvvuru Abhiram is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Feb 2004 | ₹1.75 Cr | Open |
Punjab National Bank Creation Date: 24 Jan 2002 | ₹2.00 M | Open |
Ap State Financial Corporation Creation Date: 04 Jul 1996 | ₹3.25 M | Open |
How Many Employees Work at Enpiar Pharma?
Unlock and access historical data on people associated with Enpiar Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enpiar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enpiar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
